E-selectin is a viable route of infection for polymer-coated adenovirus retargeting in TNF-α-activated human umbilical vein endothelial cells. by Bachtarzi, H, Stevenson, M, Subr, V, Seymour, L, Fisher, K

Poly(ethylene glycol) multiblock copolymer as a carrier of anti-cancer drug Doxorubicin by Pechar, M, Ulbrich, K, Šubr, V, Seymour, L, Schacht, E

Targeting adenovirus gene delivery to activated tumour-associated vasculature via endothelial selectins. by Bachtarzi, H, Stevenson, M, Šubr, V, Ulbrich, K, Seymour, L, Fisher, K

Passive tumour targeting of polymer-coated adenovirus for cancer gene therapy. by Fisher, K, Green, N, Hale, A, Subr, V, Ulbrich, K, Seymour, L

Virotherapy of ovarian cancer with polymer-cloaked adenovirus retargeted to the epidermal growth factor receptor. by Morrison, J, Briggs, S, Green, N, Fisher, K, Subr, V, Ulbrich, K, Kehoe, S, Seymour, L

Coating of adenovirus type 5 with polymers containing quaternary amines prevents binding to blood components. by Subr, V, Kostka, L, Selby-Milic, T, Fisher, K, Ulbrich, K, Seymour, L, Carlisle, R

Optimally stealthed Adenovirus serotype 5 shows enhanced activity and resistance to neutralisation by Thoma, C, Subr, V, Illingworth, S, Morrison, J, Fisher, K, Ulbrich, K, Seymour, L, Carlisle, R

Tumour necrosis factor-alpha increases extravasation of virus particles into tumour tissue by activating the Rho A/Rho kinase pathway. by Seki, T, Carroll, F, Illingworth, S, Green, N, Cawood, R, Bachtarzi, H, Subr, V, Fisher, K, Seymour, L

Tumour necrosis factor-alpha increases extravasation of virus particles into tumour tissue by activating the Rho A/Rho kinase pathway. by Seki, T, Carroll, F, Illingworth, S, Green, N, Cawood, R, Bachtarzi, H, Subr, V, Fisher, K, Seymour, L

Enhanced tumor uptake and penetration of virotherapy using polymer stealthing and focused ultrasound. by Carlisle, R, Choi, J, Bazan-Peregrino, M, Laga, R, Subr, V, Kostka, L, Ulbrich, K, Coussios, C, Seymour, L

Decreased binding to proteins and cells of polymeric gene delivery vectors surface modified with a multivalent hydrophilic polymer and retargeting through attachment of transferrin by Dash, P, Read, M, Fisher, K, Howard, K, Wolfert, M, Oupicky, D, Subr, V, Strohalm, J, Ulbrich, K, Seymour, L

Retargeting polymer-coated adenovirus to the FGF receptor allows productive infection and mediates efficacy in a peritoneal model of human ovarian cancer. by Green, N, Morrison, J, Hale, S, Briggs, S, Stevenson, M, Subr, V, Ulbrich, K, Chandler, L, Mautner, V, Seymour, L, Fisher, K

Tropism ablation and stealthing of oncolytic adenovirus enhances systemic delivery to tumors and improves virotherapy of cancer. by Green, N, Hale, A, Cawood, R, Illingworth, S, Herbert, C, Hermiston, T, Subr, V, Ulbrich, K, van Rooijen, N, Seymour, L, Fisher, K

Coating of adeno-associated virus with reactive polymers can ablate virus tropism, enable retargeting and provide resistance to neutralising antisera. by Carlisle, R, Benjamin, R, Briggs, S, Sumner-Jones, S, McIntosh, J, Gill, D, Hyde, S, Nathwani, A, Subr, V, Ulbrich, K, Seymour, L, Fisher, K

Human erythrocytes bind and inactivate type 5 adenovirus by presenting Coxsackie virus-adenovirus receptor and complement receptor 1. by Carlisle, R, Di, Y, Cerny, A, Sonnen, A, Sim, R, Green, N, Subr, V, Ulbrich, K, Gilbert, R, Fisher, K, Finberg, R, Seymour, L

Human erythrocytes bind and inactivate type 5 adenovirus by presenting Coxsackie virus-adenovirus receptor and complement receptor 1 by Carlisle, R, Di, Y, Cerny, A, Sonnen, A, Sim, R, Green, N, Subr, V, Ulbrich, K, Gilbert, R, Fisher, K, Finberg, R, Seymour, L

Adenovirus type 5 (Ad5) is sequestered and inactivated by binding to coxsackievirus and adenovirus receptor (CAR) and complement receptor 1 (CR1) on human erythrocytes by Carlisle, R, Di, Y, Cerny, A, Sonnen, A, Sim, R, Green, N, Subr, V, Ulbrich, K, Gilbert, R, Fisher, K, Finberg, R, Seymour, L